0 items USD 0.00Search
Your search for "mrrpb5 global glioblastoma multiforme therapeutics market research report 2018" gave back 451387 results.
The global Recurrent Glioblastoma Multiforme Treatment market size is expected to reach US$ 699.5 million by 2029, growing at a CAGR of 6.0% from...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
The global Recurrent Glioblastoma Multiforme Treatment market was valued at US$ 463.4 million in 2023 and is anticipated to reach US$ 699.5 million...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global Recurrent Glioblastoma Multiforme Treatment market size was valued at US$ 453.4 million in 2023. With growing demand in downstream market...
Catalog:
LPI
February 2024
Price: USD 3,660.00
Recurrent glioblastoma multiforme is the most aggressive cancer that begins within the brain. The global Recurrent Glioblastoma Multiforme (GBM)...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global Glioblastoma Multiforme Treatment (GBM) market was valued at US$ 548.3 million in 2023 and is anticipated to reach US$ 996.4 million by...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Glioma is a broad category of brain and spinal cord tumors that come from glial cells brain cells that support nerve cells.The symptoms, prognosis,...
Catalog:
MRRPB5
November 2023
Price: USD 2,900.00
The global Recurrent Glioblastoma Multiforme (GBM) Treatment market size was valued at US$ 453.4 million in 2023. With growing demand in downstream...
Catalog:
LPI
March 2024
Price: USD 3,660.00
The global Glioblastoma Multiforme Treatment (GBM) market size was valued at US$ 536.3 million in 2023. With growing demand in downstream market, the...
Catalog:
LPI
March 2024
Price: USD 3,660.00
Glioma is a broad category of brain and spinal cord tumors that come from glial cells brain cells that support nerve cells.The symptoms, prognosis,...
Catalog:
MRRPB5
May 2024
Price: USD 2,900.00
Glioblastoma also is known as glioblastoma multiforme, is a type of malignant brain tumor that develops from glial cells. It proliferates at a rapid...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Malignant gliomas, tumors derived from the neuroepithelium are collectively referred to as gliomas (gliomas), accounting for 40-50% of brain tumors,...
Catalog:
MRRPB5
March 2024
Price: USD 3,950.00
Isocitrate dehydrogenase (IDH) (EC 1.1.1.42) and (EC 1.1.1.41) is an enzyme that catalyzes the oxidative decarboxylation of isocitrate, producing...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Leucine Rich Repeat Serine/Threonine Protein Kinase 2 (Dardarin or LRRK2 or EC 2.7.11.1) – Leucine-rich repeat kinase 2 (LRRK2) is an enzyme encoded...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
The global Glutamate Carboxypeptidase 2 market size was valued at US$ million in 2023. With growing demand in downstream market, the Glutamate...
Catalog:
LPI
August 2024
Price: USD 3,660.00
Dendritic cells (part of neuron) plays an important role in inducing anti-tumor activity. Hence, various strategies are being developed to treat...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
